Incarcerated Hernias Use Of Mesh In The Acute Setting
Brian Jacob, MD
incarcerated & strangulated hernias–1:10
level of contamination–2:19
decisions–2:31
clean contaminated–4:02
what does the lit suggest?–4:36 https://www.ncbi.nlm.nih.gov/pubmed/16951968
does mesh location matter?–5:39 https://www.ncbi.nlm.nih.gov/pubmed/19890675
does mesh material matter?–6:18 https://www.ncbi.nlm.nih.gov/pubmed/?term=17952701
synthetic vs biologic mesh–6:27 https://www.ncbi.nlm.nih.gov/pubmed/?term=22907777
https://www.ncbi.nlm.nih.gov/pubmed/?term=21298542
https://www.ncbi.nlm.nih.gov/pubmed/24045140
international hernia collaboration–9:39 https://www.facebookstories.com/stories/99818/revolutionizing-surgery-through-worldwide-collaboration
summary–12:29
Keyword(s): abdominal wall defects, Bard soft mesh, biofilm, biologic grafts, biologic mesh, CDC wound class, Davol, Ethicon, fistula, foreign body reaction, hernia repair, IH, in vivo, incarcerated hernia, international hernia collaboration, LWLP PPM, MRSA, ostomy reversal, Prolene soft, pus, rectorectus space, seroma, SSI, strangulated hernia, synthetic mesh, Ultrapro, umbilical hernia, VHR, wound infection